CX 2018 Presentations
Please note: Some presentations may not be available as permission may not have been given.
PERIPHERAL CRITICAL ISCHAEMIA CONTROVERSIES - Thursday, 26th April
Venue: Lower Main Auditorium
Time: 08:00 - 18:00
CX iLegx 10 year celebrations & Welcome to the CLI Global Society
| Chairing: | Barry Katzen, Miami, United States |
| Moderator: | Cliff Shearman, Southampton, United Kingdom |
Multidisciplinary controversies
Improving outcomes of lower limb revascularisation-findings from a one nationwide routine dataset of 104,000 patients in England
| Speaker: | Ian Loftus, London, United Kingdom |
Time: 08:07 - 08:14
How to change a service and the stages of changing a service
| Speaker: | Cliff Shearman, Southampton, United Kingdom |
Time: 08:14 - 08:21
To save limbs, a multidisciplinary team is vital-the CLI Global Society approach
| Speaker: | Richard Neville, Annandale, United States |
Time: 08:31 - 08:38
Peripheral arterial disease integrated care pathway
| Speaker: | Martin Fox, Manchester, United Kingdom |
Time: 08:38 - 08:45
Manchester Amputation Reduction Strategy
| Speaker: | Naseer Ahmad, Manchester, United Kingdom |
Time: 08:45 - 08:55
The national diabetic footcare audit (NDFA)-the hazard of delays in referral to interdisciplinary clinic with a diabetologist and vascular surgeon
| Speaker: | William Jeffcoate, Nottingham, United Kingdom |
Time: 08:55 - 09:02
Popliteal artery injury associated with knee trauma
| Speaker: | Martin Björck, Uppsala, Sweden |
Time: 09:12 - 09:19
The remaining place for distal bypasses in below-the-knee treatment
| Speaker: | Eric Ducasse, Bordeaux, France |
Time: 09:19 - 09:26
Preventing major amputation-the cost for the patient and the health care system
| Speaker: | Dominic Howard, Oxford, United Kingdom |
Time: 09:26 - 09:33
Advances in atherectomy-hybrid atherectomy for superficial femoral artery and below the knee
| Speaker: | Michael Lichtenberg, Arnsberg, Germany |
Coffee and visit to hands-on workshops
Time: 10:00 - 10:30
Novel treatment strategy with intravascular lithotripsy for calcified, arterial stenosis
| Chairing: | Andrew Holden, Auckland, New Zealand |
| Panel: | Marianne Brodmann, Graz, Austria |
| Arne Schwindt, Münster, Germany |
Time: 10:30 - 10:50
Live case: Using intravascular lithotripsy to treat infrapopliteal arterial calcification
| Speaker: | Thomas Zeller, Bad Krozingen, Germany |
Time: 10:50 - 11:00
Audience participation and discussion
Time: 11:00 - 11:05
Impact of intravascular lithotripsy on calcium
| Speaker: | Andrew Holden, Auckland, New Zealand |
Time: 11:05 - 11:10
Overview of peripheral intravascular lithotripsy clinical programmes
| Speaker: | Marianne Brodmann, Graz, Austria |
Time: 11:10 - 11:15
Practical experience and utilisation of intravascular lithotripsy in calcified peripheral arterial stenosis
| Speaker: | Arne Schwindt, Munster, Germany |
Time: 11:15 - 11:20
Intravascular lithotripsy for infrapopliteal arterial stenosis (edited case)
| Speaker: | Andrew Holden, Auckland, New Zealand |
Controversies on technologies and techniques for severe critical ischaemia
| Chairing: | Frans Moll, Utrecht, Netherlands |
| Moderator: | Trevor Cleveland, Sheffield, United Kingdom |
Time: 11:40 - 11:48
Improved DCB results for below the knee in China
| Speaker: | Wei Guo, Beijing, China |
Time: 11:48 - 11:56
Improvement of outcomes DCB-BTK vs. POBA: RCTs in Italy
| Speaker: | Francesco Liistro, Arezzo, Italy |
Time: 12:05 - 12:13
Percutaneous femoropopliteal bypass the DETOUR 1 trial
| Speaker: | Jihad Mustapha, Wyoming, United States |
Time: 12:13 - 12:22
Outcomes of arterialisation of the foot veins-early experiences
| Speaker: | Daniela Branzan, Leipzig, Germany |
Lunch and visit to hands-on workshops
Time: 12:30 - 13:30
Peripheral arterial calcification - mechanism of action, detection, classification and clinical implications
| Chairing: | Michael Edmonds, London, United Kingdom |
| Moderator: | Peter Schneider, Honolulu, United States |
Time: 13:30 - 13:38
Comparing trial data in the management of calcified arteries
| Speaker: | Andrew Holden, Auckland, New Zealand |
Time: 13:38 - 13:46
Causes of vascular calcification
| Speaker: | Catherine Shanahan, London, United Kingdom |
Time: 13:46 - 13:54
Character and localisation of arterial calcification
| Speaker: | Renu Virmani, Gaithersburg, United States |
Time: 14:09 - 14:17
The impact of calcification on six months' efficacy when using drug-coated balloons in the superficial femoral artery-the SELUTION trial
| Speaker: | Thomas Albrecht, Berlin, Germany |
Time: 14:17 - 14:25
Significance of calcification
| Speaker: | Marlon Spreen, The Hague, Netherlands |
Time: 14:25 - 14:33
Management of calcification-lithotripsy
| Speaker: | Andrew Holden, Auckland, New Zealand |
Time: 14:48 - 14:56
Lithotripsy for preparation of severely calcified lesions
| Speaker: | Marianne Brodmann, Graz, Austria |
Time: 14:56 - 15:04
Treatment options to increase drug uptake in calcified vessels
| Speaker: | Fabrizio Fanelli, Florence, Italy |
Time: 15:04 - 15:12
The challenge of calcification
| Speaker: | Brian DeRubertis, Los Angeles, United States |
Tea and visit to hands-on workshops
Time: 15:30 - 16:00
Revascularisation considerations and wound care
| Chairing: | Robert Hinchliffe, Bristol, United Kingdom |
| Moderator: | Richard Neville, Annandale, United States |
Time: 16:00 - 16:08
Podium 1st: Below-the-knee dedicated sirolimus eluting-stent
| Speaker: | Kim Taeymans, Belgium |
Time: 16:08 - 16:16
Contrast-enhanced ultrasound visualisation of micro channels can identify occusions suitable for luminal endovascular crossing
| Speaker: | Ian Spark, Kingswood, Australia |
Time: 16:16 - 16:24
Drug-coated balloons vs. balloon angioplasty in bypass vein grafts-a randomised controlled study with one-year follow-up (the DRECOREST study)
| Speaker: | Patrick Björkman, Helsinki, Finland |
Time: 16:42 - 16:50
Factors, conditions and treatment can enhance tissue regeneration in ischaemic foot wounds after revascularisation
| Speaker: | Magdiel Trinidad, Colorado Spring, United States |
Time: 16:50 - 16:58
Matrix metalloproteinase inhibitor dressing
| Speaker: | Michael Edmonds, London, United Kingdom |
Time: 17:08 - 17:16
Managing leg ulcers in the community-what is possible and feasible
| Speaker: | Manj Gohel, Cambridge, United Kingdom |
Time: 17:16 - 17:24
Novel nitric oxide release dressing
| Speaker: | Michael Edmonds, London, United Kingdom |
Time: 17:34 - 17:42
Below-the-knee prosthetic bypass
| Speaker: | Walter Dorigo, Florence, Italy |
Time: 17:42 - 17:50
Update on ongoing below-the-knee registry
| Speaker: | Michael Lichtenberg, Arnsberg, Germany |